drugset
drugset / Trial / NCT00609284

Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux

NCT00609284 ↗

Phase 3 Completed 406 enrolled Groupe Oncologie Radiotherapie Tete et Cou
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the trial is to study the efficacy of adding concomitant chemotherapy (carboplatin/5FU) to Erbitux-radiotherapy in patients with locally advanced head and neck cancer.

Timeline

Start
2008-02-15
Primary completion
2018-03-26
Completion
2019-03-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 70 mg/m2 —
Subject fluorouracil Small molecule 600 mg/m2 —
Background Cetuximab Monoclonal antibody — —

Indications

head and neck squamous cell carcinoma